Ireland’s healthcare debate is shifting from public versus private toward a practical question of how both can add capacity. In September 2026, Stephen Beale of Cardinal Capital Group argued in the Irish Independent that private capital can help bring the Irish healthcare sector closer to OECD capacity levels, citing 2.9 per 1,000 people against an OECD average of about 4.2. For private hospitals, this reframing is an invitation to lead with credible, well-governed capacity plans. Beale puts the gap at roughly 7,000 additional beds.

The argument deserves commendation for its pragmatism. Beale’s view is that national needs are best served by a combination of public and private healthcare provision. Newstalk reported in October 2026 that more than €1 billion of private investment could be required over five years. Providers that pair new capacity with healthcare excellence in outcomes, access, and communication will be the partners that capital and policymakers prefer. Beale adds that experienced private providers can bring international best practice.

Private investment has already added capacity across settings. A Cardinal-backed expansion at Sports Surgery Clinic planned two additional theatres and a 40% rise in surgical capacity, while a €30m investment in Cathedral Eye Clinic supports a planned Dublin ophthalmology unit. Healthcare providers that expand with clear specialty focus deliver a patient experience defined by shorter waits, purpose-built facilities, and consistent clinical teams. The common thread is targeted expansion in specialties where demand is clear.

The demand base supports this ambition. The Insurance Ireland and Milliman report, published December 2025, confirms private health insurance paid out over €3 billion in claims in 2024 across 2.55 million insured people. Healthcare professionals choose to practise where theatres, diagnostics, and teams are modern and available. Investment in healthcare technology, from digital scheduling to advanced imaging, turns new beds and theatres into productive clinical environments. That insured base gives investors confidence that new capacity will be used.

Capacity alone is not the goal; deployment matters. Healthcare leadership that treats new beds as part of an integrated pathway, linking GP referral, diagnostics, surgery, and step-down care, will make better use of every euro invested. Mowlam Healthcare’s step-down and memory care model shows how capacity beyond acute hospitals supports patient flow. Operational excellence in healthcare is what converts capital into measurable access.

Three actions will prepare private providers for this moment. First, develop an investment-ready capacity plan with specific bed, theatre, and diagnostic targets by specialty. Second, build outcomes and access reporting that investors, insurers, and commissioners can verify. Third, apply healthcare leadership and management discipline and medical innovation to pathway design, so each new unit is planned around clinical demand rather than estate alone.

Ireland’s capacity ambition is large and the policy conversation is maturing. For private healthcare, the opportunity is to be seen as a constructive partner rather than a parallel system. Those who bring healthcare innovation and credible capacity plans to this conversation will help close the gap with the OECD and earn a lasting role in how Irish health infrastructure is built.